Black Bird Biotech (BBBT) Stock Sees Profit Booking At Higher Level

Black Bird Biotech (OTCMKTS:BBBT), which is best known for making the plant based biopesticide manufacturer named MiteXstream, has seen its stock tank over the course of the past few days.

The carnage continued on Monday as the Black Bird stock declined by another 45% and took its losses for the past week to as much as 135%. While the losses made by the stock are alarming, it is also necessary to remember at the same time that there has been no news at all about the company over the past week.

The last time any news emerged about Black Bird was back on July 21 when the company announced that it was going to look for EPA approval for the ready to use variant of MiteXstream. The company noted that it was the first step for Black Bird if it was to enter the lucrative home gardening space.

The President of the company, Fabian Denault spoke about the rationale behind the move as well. He stated that the company believes that MiteXstream could be the ideal solution for people who want to keep their home gardens devoid of pests and mildews. It now remains to be seen if the Black Bird stock can actually make a recovery over the coming days.